Pacira Biosciences
PCRX
#5835
Rank
HK$8.39 B
Marketcap
HK$186.75
Share price
0.04%
Change (1 day)
24.57%
Change (1 year)
Categories

Market capitalization of Pacira Biosciences (PCRX)

Market cap: HK$8.39 Billion

As of December 2025 Pacira Biosciences has a market cap of HK$8.39 Billion. This makes Pacira Biosciences the world's 5835th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Pacira Biosciences from 2011 to 2025

End of year Market Cap

Year Marketcap Change
2025HK$8.39 B19.13%
2024HK$7.04 B-42.44%
2023HK$12.23 B-11.59%
2022HK$13.84 B-33.77%
2021HK$20.89 B3.7%
2020HK$20.15 B36.31%
2019HK$14.78 B6.47%
2018HK$13.88 B-4.02%
2017HK$14.46 B54.46%
2016HK$9.36 B-57.28%
2015HK$21.93 B-11.78%
2014HK$24.86 B65.79%
2013HK$14.99 B239.44%
2012HK$4.41 B281.65%
2011HK$1.15 B

End of Day market cap according to different sources

On Dec 6th, 2025 the market cap of Pacira Biosciences was reported to be:

HK$8.03 Billion
by Nasdaq info icon info icon
HK$8.39 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Recro Pharma
REPH
HK$0.95 B-88.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Flexion Therapeutics
FLXN
HK$3.57 B-57.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Cara Therapeutics
CARA
HK$63.13 M-99.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Heron Therapeutics
HRTX
HK$1.86 B-77.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Omeros Corporation
OMER
HK$5.98 B-28.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Zogenix
ZGNX
HK$11.67 B 39.17%๐Ÿ‡บ๐Ÿ‡ธ USA